Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study Using Targeted Therapy in NSCLC

Scientific Reports - United Kingdom
doi 10.1038/srep41197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P2.04-17 Pre-Therapy Radiomic Features Can Distinguish Hyperprogression From Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Defining a Unified Vascular Phenotype in Systemic Sclerosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Quantitative Approach to Skin Field Cancerization Using a Nanoencapsulated Photodynamic Therapy Agent: A Pilot Study

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2013English

Targeted Alpha Therapy Using Astatine (211At)-Labeled Phenylalanine: A Preclinical Study in Glioma Bearing Mice

Oncotarget
Oncology
2020English

Response Distortion in Adolescents Who Smoke: A Pilot Study

Journal of Drug Education
Mental HealthEnvironmentalPublic HealthPsychiatryHealthMedicineOccupational Health
2002English

Pentoxifylline Therapy for Hepatopulmonary Syndrome: A Pilot Study

Archives of Internal Medicine
2008English

MRI in Predicting the Response of Gastrointestinal Stromal Tumor to Targeted Therapy: A Patient-Based Multi-Parameter Study

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Pcn125 - First Insights Into Comparing Expenditures for Targeted Therapy and Survival in NSCLC

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy